DOTA Conjugated JM#21 derivative 7

This research compound, Ligand-7, is a DOTA-conjugated CXCR4-targeting peptide derivative. When radiolabeled with 177Lu, it forms a targeted radioligand with high tumor specificity and low non-target organ uptake in biodistribution studies, making it suitable for oncology and molecular imaging research.